An AIDS drug-price war
Last week, Yusuf Hamied the chairman of Bombay pharmaceutical firm Cipla announced that the company would provide AIDS cocktails to be distributed through Medecins sans Frontieres, the non-profit
Related Content
- Trans-Pacific trade pact triggers fears over drug prices
- Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries
- Govt to put price limit on 348 essential drugs
- Bio-business in brief: a case for new drugs at generic prices from India
- A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries
- The global partnership for development: Time to deliver